ETON
NASDAQ · Pharmaceuticals
Eton Pharmaceuticals Inc
$29.93
-1.09 (-3.51%)
Open$30.73
Previous Close$31.02
Day High$30.93
Day Low$29.75
52W High$32.31
52W Low$13.09
Volume—
Avg Volume440.0K
Market Cap846.36M
P/E Ratio—
EPS$-0.17
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
-60.1% upside
Current
$29.93
$29.93
Target
$11.93
$11.93
$8.04
$11.93 avg
$13.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 84.02M | 54.02M | 122.17M |
| Net Income | -4,835,562 | -2,798,177 | 16.25M |
| Profit Margin | -5.8% | -5.5% | 13.3% |
| EBITDA | 3.36M | 2.05M | 25.36M |
| Free Cash Flow | — | — | 11.15M |
| Rev Growth | +55.5% | +55.5% | -8.5% |
| Debt/Equity | 1.17 | 1.17 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |